Across four prospective U.S. cohorts, 4.5% of those 18-49 years old met criteria for COPD, defined as spirometric airflow ...

According to the World Heath Organization (WHO), chronic obstructive pulmonary disease (COPD) is the third leading cause of ...

Medically reviewed by Sanja Jelic, MD Asthma and chronic obstructive pulmonary disease (COPD) are chronic respiratory (lung) diseases that cause breathing difficulty and coughing. Asthma affects about ...

Patients with COPD and chronic hypercapnic respiratory failure on noninvasive ventilation report similar quality of life ...

PROGRAM OVERVIEW. Asthma and COPD are common obstructive lung diseases that affect a large portion of the population. Although they share similar symptoms, their underlying pathophysiology differs ...

Roche’s hopes of getting its chronic obstructive pulmonary disease (COPD) drug astegolimab to regulators this year have taken ...

The path to market for Roche’s astegolimab became more uncertain after the investigational antibody failed to significantly ...

A panel of the European medicines regulator has recommended approving an eco-friendly version of AstraZeneca's inhaler for the treatment of a chronic lung condition, the drugmaker said on Friday.

Personalized care for patients with obstructive lung disease: uncover the ‘treatable traits’ concept and how it’s reshaping treatment strategies for better patient management.

Urine VOCs are linked to COPD risk and inflammation in NHANES data, suggesting potential for non-invasive screening with ...

Severe gum disease has been linked to the progression of chronic obstructive pulmonary disease, or COPD, but an understanding of how the connection plays out in the immune system remains unclear.